(Q52273764)

28 April 2018

title

Myths about the treatment of addiction. (English)

1 reference

28 April 2018

author name string

C P O'Brien

series ordinal

1

1 reference

28 April 2018

A T McLellan

series ordinal

2

1 reference

28 April 2018

language of work or name

English

0 references

publication date

1 January 1996

1 reference

28 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

The Lancet

1 reference

28 April 2018

volume

347

1 reference

28 April 2018

issue

8996

1 reference

28 April 2018

page(s)

237-240

1 reference

28 April 2018

Are detoxification programmes effective?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Low level of response to alcohol as a predictor of future alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Career dynamics of female heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Matching substance abuse patients to appropriate treatments: a conceptual and methodological approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

The antisocial personality disorder diagnosis in substance abusers: problems and issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Dropout and relapse during diabetes care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Treatment adherence and risk of death after a myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Improving compliance and increasing control of hypertension: needs of special hypertensive populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Adherence to diabetes regimens: empirical status and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Compliance to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

Hypertension and ischemic heart disease: the challenge of the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990409-2

7 January 2021

10.1016/S0140-6736(96)90409-2

Identifiers

DOI

1 reference

28 April 2018

PubMed ID

8551886

1 reference

28 April 2018